The Global Project Leader provides strategic and operational leadership for one or more global clinical development programs within a complex, global rare disease portfolio, spanning early development through registration and lifecycle management. The role drives integrated program strategy, execution, and decision-making within a global, matrixed governance model, partnering closely with cross-functional and headquarters stakeholders. The Global Project Leader is accountable for shaping strategic recommendations, enabling high-quality governance, and ensuring delivery of program objectives aligned with portfolio priorities and long-term patient impact.
This role is critical to ensuring that Shionogi’s rare disease portfolio is advanced with agility, rigor, and long-term patient impact in mind.
ResponsibilitiesResponsibilities:- Lead global, cross-functional program teams across the full development lifecycle (early, late, registration, lifecycle management) for rare disease assets.
- Define and drive integrated program strategies aligned with clinical, regulatory, CMC, and commercial objectives.
- Contribute to rare disease portfolio strategy, including prioritization, sequencing, and portfolio trade-off decisions across programs.
- Translate complex scientific, clinical, and regulatory data into clear strategic options and decision frameworks for senior leadership.
- Serve as a core leader in governance forums, delivering high-quality, decision-ready materials aligned with enterprise priorities.
- Drive structured, transparent decision-making across global stakeholders within a matrixed governance model, including close partnership with headquarters.
- Oversee integrated development plans, critical milestones, and cross-functional execution to ensure delivery against strategic objectives.
- Ensure accountability, execution discipline, and proactive resolution of risks impacting timelines, quality, or program viability.
- Lead lifecycle management strategy, including label expansion, geographic expansion, and integration of real-world evidence.
- Identify, assess, and mitigate program and portfolio risks; lead scenario planning and complex trade-off decisions under uncertainty, including challenges specific to rare disease development.
- Accountable for program-level resource planning, financial assumptions, and alignment with portfolio investment priorities.
- Influence and align global cross-functional stakeholders across regions (U.S., EU, APAC) and external partners (e.g., regulators, KOLs, advocacy groups) to advance program objectives.
- Mentor and develop talent, and drive continuous improvement in program leadership capabilities, tools, and operating model effectiveness.
- Other duties as assigned.
- Bachelor’s degree required; advanced degree (PhD, PharmD, MD, MS, MBA) strongly preferred.
- 12+ years of experience in pharmaceutical/biotechnology development with demonstrated leadership in global, cross-functional settings; experience in rare disease development strongly preferred.
- Demonstrated experience across multiple phases of drug development, with strong understanding of the end-to-end development lifecycle, including regulatory pathways.
- Proven ability to drive program strategy and execution in matrixed organizations and within structured governance models.
- Strong track record of engaging and influencing senior leadership; ability to synthesize complexity into clear decision options and recommendations.
- Experience working effectively with external stakeholders (e.g., regulators, KOLs, advocacy groups, partners) in a compliant and coordinated manner.
- Demonstrated ability to operate with portfolio-level thinking and to transition across indications/programs as portfolio needs evolve.
- Proven ability to mentor and develop program/project management talent and contribute to building organizational capability.
Preferred
- Experience leading development programs in highly complex, rapidly evolving rare neurodegenerative diseases with substantial scientific, clinical, and regulatory uncertainty.
- Broader experience in rare disease / orphan drug development and/or specialty therapeutics.
- Experience with post-approval LCM (label expansion, RWE integration, lifecycle value planning).
- Experience collaborating with headquarters-led decision-making structures in a global organization.
- Operates within a matrixed global governance model where decision authority is shared; accountable for shaping recommendations, driving alignment, and ensuring execution against agreed decisions.
- Ability and willingness to travel approximately 25–35% of the year both domestically and internationally.
- Must live a commutable distance to our US Corporate Headquarters in Florham Park, NJ. Office presence required at least 50% of the time per month.
Additional Information
The base salary range for this full-time position is $285,000 - $315,000. Individual pay is determined by several factors, which include but are not limited to: job-related skills, experience, and relevant education or training. The range does not include the comprehensive benefits, bonus, long-term incentive, applicable allowances, or any additional compensation that may be associated with this role.
EEOShionogi Inc. is an equal opportunity employer supporting individuals with disabilities and veterans. All qualified applicants will receive equal consideration for employment opportunities based on valid job requirements without regard to race, color, religion, sex (including pregnancy), marital status, national origin, age, ancestry, citizenship, disability, genetic information, status as a disabled veteran, a recently separated veteran, Active Duty Wartime or Campaign Badge Veterans, and Armed Forces Service Medal Veterans, or any other characteristic protected by applicable law.
It is the policy of Shionogi Inc. to undertake affirmative action for protected veterans and individuals with disabilities in compliance with all federal, state, and local requirements to recruit a diverse pool of protected veteran and individuals with disabilities applicants and to ensure that our employment practices are, in fact, non-discriminatory.
If you are qualified individual with a disability or a disabled veteran, you may request a reasonable accommodation if you are unable or limited in your ability to use or access this website to apply for a vacancy as a result of your disability. You can request accommodations by calling 973-307-3550 or by sending an email to [email protected].
Skills Required
- Bachelor's degree
- Advanced degree such as PhD, PharmD, MD, MS, or MBA
- 12+ years of experience in pharmaceutical or biotechnology development
- Leadership experience in global, cross-functional settings
- Experience across multiple phases of drug development and understanding of the end-to-end development lifecycle
- Understanding of regulatory pathways
- Experience driving program strategy and execution in matrixed organizations and structured governance models
- Experience engaging and influencing senior leadership
- Ability to synthesize complex information into decision options and recommendations
- Experience working with regulators, key opinion leaders, advocacy groups, and partners
- Portfolio-level thinking and ability to transition across indications or programs
- Ability to mentor and develop program or project management talent
- Experience leading development programs in complex rare neurodegenerative diseases
- Broader rare disease, orphan drug, or specialty therapeutics experience
- Experience with post-approval lifecycle management, label expansion, and real-world evidence integration
- Experience collaborating with headquarters-led decision-making structures in a global organization
- Willingness to travel approximately 25-35% domestically and internationally
- Must live within commuting distance of Florham Park, New Jersey headquarters
- Office presence required at least 50% of the time per month
What We Do
Shionogi B.V. (known as “Shionogi Europe”) is the European headquarters of Shionogi & Co., Ltd, a leading global research-driven pharmaceutical company based in Osaka, Japan. Since 1878, Shionogi has been striving to supply the best possible medicines to protect the health and wellbeing of the patients we serve. We are dedicated to finding innovative solutions for pressing unmet clinical needs, and have a strong track record in discovering and developing novel medicines for antimicrobial resistance (AMR), HIV and influenza. Alongside our work in infectious diseases, we also have extensive expertise in other areas of unmet clinical needs within our Hospital Specialty Business, and a strong track record in other therapy areas affecting quality of life, particularly Women’s Health. Since launching in Europe in 2012, we have significantly expanded our presence and now have coverage of the biggest markets in the continent. Our offices in Amsterdam, Berlin, London, Madrid, Paris and Rome provide the bases for over 300 passionate staff from across the spectrum of big pharma and biotech, as well as experts in technology, creatives, entrepreneurs and others - who come together to do things differently and better. Our culture is unique, blending our Japanese roots with our strong and rapidly growing European operation. We have a friendly, inclusive work environment and aim to foster a culture that encourages our people to break out of the boundaries of the traditional pharmaceutical company. Through successful strategic partnerships and open collaboration, we are determined to shape the future of healthcare. Our ambitious growth plans include extending the reach of our marketed products, developing our innovative pipeline of medicines and securing the right partnerships and acquisitions to accelerate our development. To find out about partnering with us, visit: https://t.ly/YzlSu For career opportunities, visit: https://t.ly/mERcQ NP-EU-NP-0303 DOP July 2024
.png)






